Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00150982 · ClinicalTrials.gov registry record · Phase 2
Alefacept Mechanism of Action in Psoriasis
A Phase 2 study, sponsored by University of Medicine and Dentistry of New Jersey.
- Completed
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT00150982 is a Phase 2 study that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 9 participants.
The verdict
NCT00150982, a Phase 2 study, has completed, sponsored by University of Medicine and Dentistry of New Jersey.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
To determine the mechanism of action of alefacept in patients with psoriasis.
Interventions
- DRUG Mechanism of action of alefacept
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2003-09 |
| Est. Completion | 2005-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00150982
The ClinicalTrials.gov registry entry for NCT00150982 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Medicine and Dentistry of New Jersey, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mechanism of action of alefacept is the first listed.
NCT00150982 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00150982 about?
NCT00150982 is a clinical study titled "Alefacept Mechanism of Action in Psoriasis". To determine the mechanism of action of alefacept in patients with psoriasis.
What is the current status of trial NCT00150982?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2003-09. Estimated completion is 2005-02.
What interventions are being tested in trial NCT00150982?
The interventions under investigation include: Mechanism of action of alefacept (DRUG).
Who is sponsoring clinical trial NCT00150982?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.